Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Efficacy and safety of buparlisib, a PI3K inhibitor, in patients with malignancies harboring a PI3K pathway activation: a phase 2, open-label, single-arm study.

Piha-Paul SA, Taylor MH, Spitz D, Schwartzberg L, Beck JT, Bauer TM, Meric-Bernstam F, Purkayastha D, Karpiak L, Szpakowski S, Braiteh F.

Oncotarget. 2019 Nov 5;10(60):6526-6535. doi: 10.18632/oncotarget.27251. eCollection 2019 Nov 5.

2.

TRPM1 Autoantibodies in Melanoma Patients Without Self-Reported Visual Symptoms.

Duvoisin RM, Ren G, Haley TL, Taylor MH, Morgans CW.

Invest Ophthalmol Vis Sci. 2019 May 1;60(6):2330-2335. doi: 10.1167/iovs.19-26775.

3.

Characterisation of aluminium release by the enFlow® fluid-warming system in crystalloids and blood products.

Taylor MH, Choi D, Fitzpatrick SM, Gunn KN.

Anaesthesia. 2019 Nov;74(11):1374-1380. doi: 10.1111/anae.14697. Epub 2019 May 7.

PMID:
31066048
4.

Tumor immune microenvironment characteristics of papillary thyroid carcinoma are associated with histopathological aggressiveness and BRAF mutation status.

Means C, Clayburgh DR, Maloney L, Sauer D, Taylor MH, Shindo ML, Coussens LM, Tsujikawa T.

Head Neck. 2019 Aug;41(8):2636-2646. doi: 10.1002/hed.25740. Epub 2019 Mar 21.

PMID:
30896061
5.

Correction: Eocene metatherians from Anatolia illuminate the assembly of an island fauna during Deep Time.

Métais G, Coster PM, Kappelman JW, Licht A, Ocakoğlu F, Taylor MH, Beard KC.

PLoS One. 2019 Feb 22;14(2):e0212985. doi: 10.1371/journal.pone.0212985. eCollection 2019.

6.

Treatment of chemotherapy-associated cardiomyopathy.

Cai AW, Taylor MH, Ramu B.

Curr Opin Cardiol. 2019 May;34(3):296-302. doi: 10.1097/HCO.0000000000000614.

PMID:
30747732
7.

Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer: Phase 1b Results From the JAVELIN Solid Tumor Trial.

Disis ML, Taylor MH, Kelly K, Beck JT, Gordon M, Moore KM, Patel MR, Chaves J, Park H, Mita AC, Hamilton EP, Annunziata CM, Grote HJ, von Heydebreck A, Grewal J, Chand V, Gulley JL.

JAMA Oncol. 2019 Mar 1;5(3):393-401. doi: 10.1001/jamaoncol.2018.6258.

8.

Avelumab in patients with previously treated metastatic melanoma: phase 1b results from the JAVELIN Solid Tumor trial.

Keilholz U, Mehnert JM, Bauer S, Bourgeois H, Patel MR, Gravenor D, Nemunaitis JJ, Taylor MH, Wyrwicz L, Lee KW, Kasturi V, Chin K, von Heydebreck A, Gulley JL.

J Immunother Cancer. 2019 Jan 16;7(1):12. doi: 10.1186/s40425-018-0459-y.

9.

Efficacy and Safety of Avelumab Treatment in Patients With Advanced Unresectable Mesothelioma: Phase 1b Results From the JAVELIN Solid Tumor Trial.

Hassan R, Thomas A, Nemunaitis JJ, Patel MR, Bennouna J, Chen FL, Delord JP, Dowlati A, Kochuparambil ST, Taylor MH, Powderly JD, Vaishampayan UN, Verschraegen C, Grote HJ, von Heydebreck A, Chin K, Gulley JL.

JAMA Oncol. 2019 Mar 1;5(3):351-357. doi: 10.1001/jamaoncol.2018.5428.

10.

Eocene metatherians from Anatolia illuminate the assembly of an island fauna during Deep Time.

Métais G, Coster PM, Kappelman JR, Licht A, Ocakoğlu F, Taylor MH, Beard KC.

PLoS One. 2018 Nov 14;13(11):e0206181. doi: 10.1371/journal.pone.0206181. eCollection 2018. Erratum in: PLoS One. 2019 Feb 22;14(2):e0212985.

11.

Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention.

Walter KR, Ford ME, Gregoski MJ, Kramer RM, Knight KD, Spruill L, Nogueira LM, Krisanits BA, Phan V, La Rue AC, Lilly MB, Ambs S, Chan K, Turner TF, Varner H, Singh S, Uribarri J, Garrett-Mayer E, Armeson KE, Hilton EJ, Clair MJ, Taylor MH, Abbott AM, Findlay VJ, Peterson LL, Magwood G, Turner DP.

Breast Cancer Res Treat. 2019 Feb;173(3):559-571. doi: 10.1007/s10549-018-4992-7. Epub 2018 Oct 27.

12.

Survival of Listeria innocua on Fuji apples under commercial cold storage with or without low dose continuous ozone gaseous.

Sheng L, Hanrahan I, Sun X, Taylor MH, Mendoza M, Zhu MJ.

Food Microbiol. 2018 Dec;76:21-28. doi: 10.1016/j.fm.2018.04.006. Epub 2018 Apr 13.

PMID:
30166144
13.

Safety profile of avelumab in patients with advanced solid tumors: A pooled analysis of data from the phase 1 JAVELIN solid tumor and phase 2 JAVELIN Merkel 200 clinical trials.

Kelly K, Infante JR, Taylor MH, Patel MR, Wong DJ, Iannotti N, Mehnert JM, Loos AH, Koch H, Speit I, Gulley JL.

Cancer. 2018 May 1;124(9):2010-2017. doi: 10.1002/cncr.31293. Epub 2018 Feb 22.

14.

Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US Preventive Services Task Force controversy.

Johnson MM, Leachman SA, Aspinwall LG, Cranmer LD, Curiel-Lewandrowski C, Sondak VK, Stemwedel CE, Swetter SM, Vetto J, Bowles T, Dellavalle RP, Geskin LJ, Grossman D, Grossmann KF, Hawkes JE, Jeter JM, Kim CC, Kirkwood JM, Mangold AR, Meyskens F, Ming ME, Nelson KC, Piepkorn M, Pollack BP, Robinson JK, Sober AJ, Trotter S, Venna SS, Agarwala S, Alani R, Averbook B, Bar A, Becevic M, Box N, E Carson W 3rd, Cassidy PB, Chen SC, Chu EY, Ellis DL, Ferris LK, Fisher DE, Kendra K, Lawson DH, Leming PD, Margolin KA, Markovic S, Martini MC, Miller D, Sahni D, Sharfman WH, Stein J, Stratigos AJ, Tarhini A, Taylor MH, Wisco OJ, Wong MK.

Melanoma Manag. 2017 Mar;4(1):13-37. doi: 10.2217/mmt-2016-0022. Epub 2017 Mar 1. Review.

15.

Defining Radioiodine-Refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-Refractory Criteria in the SELECT Trial.

Kiyota N, Robinson B, Shah M, Hoff AO, Taylor MH, Li D, Dutcus CE, Lee EK, Kim SB, Tahara M.

Thyroid. 2017 Sep;27(9):1135-1141. doi: 10.1089/thy.2016.0549. Epub 2017 Aug 14.

16.

Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors.

Burris HA, Infante JR, Ansell SM, Nemunaitis JJ, Weiss GR, Villalobos VM, Sikic BI, Taylor MH, Northfelt DW, Carson WE 3rd, Hawthorne TR, Davis TA, Yellin MJ, Keler T, Bullock T.

J Clin Oncol. 2017 Jun 20;35(18):2028-2036. doi: 10.1200/JCO.2016.70.1508. Epub 2017 May 2. Erratum in: J Clin Oncol. 2019 Feb 1;37(4):359.

PMID:
28463630
17.

Academic Cancer Center Phase I Program Development.

Frankel AE, Flaherty KT, Weiner GJ, Chen R, Azad NS, Pishvaian MJ, Thompson JA, Taylor MH, Mahadevan D, Lockhart AC, Vaishampayan UN, Berlin JD, Smith DC, Sarantopoulos J, Riese M, Saleh MN, Ahn C, Frenkel EP.

Oncologist. 2017 Apr;22(4):369-374. doi: 10.1634/theoncologist.2016-0409. Epub 2017 Mar 17.

18.

Characterization of Tumor Size Changes Over Time From the Phase 3 Study of Lenvatinib in Thyroid Cancer.

Robinson B, Schlumberger M, Wirth LJ, Dutcus CE, Song J, Taylor MH, Kim SB, Krzyzanowska MK, Capdevila J, Sherman SI, Tahara M.

J Clin Endocrinol Metab. 2016 Nov;101(11):4103-4109. Epub 2016 Aug 22.

19.

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.

Hodi FS, Chesney J, Pavlick AC, Robert C, Grossmann KF, McDermott DF, Linette GP, Meyer N, Giguere JK, Agarwala SS, Shaheen M, Ernstoff MS, Minor DR, Salama AK, Taylor MH, Ott PA, Horak C, Gagnier P, Jiang J, Wolchok JD, Postow MA.

Lancet Oncol. 2016 Nov;17(11):1558-1568. doi: 10.1016/S1470-2045(16)30366-7. Epub 2016 Sep 9.

20.

Spatially-Resolved Influence of Temperature and Salinity on Stock and Recruitment Variability of Commercially Important Fishes in the North Sea.

Akimova A, Núñez-Riboni I, Kempf A, Taylor MH.

PLoS One. 2016 Sep 1;11(9):e0161917. doi: 10.1371/journal.pone.0161917. eCollection 2016.

21.

Treatment patterns, health state, and health care resource utilization of patients with radioactive iodine refractory differentiated thyroid cancer.

Gianoukakis AG, Flores NM, Pelletier CL, Forsythe A, Wolfe GR, Taylor MH.

Cancer Manag Res. 2016 May 30;8:67-76. doi: 10.2147/CMAR.S102383. eCollection 2016.

22.

Open-label, multicenter, phase 1 study of alisertib (MLN8237), an aurora A kinase inhibitor, with docetaxel in patients with solid tumors.

Graff JN, Higano CS, Hahn NM, Taylor MH, Zhang B, Zhou X, Venkatakrishnan K, Leonard EJ, Sarantopoulos J.

Cancer. 2016 Aug 15;122(16):2524-33. doi: 10.1002/cncr.30073. Epub 2016 May 18.

23.

Non-Random Variability in Functional Composition of Coral Reef Fish Communities along an Environmental Gradient.

Plass-Johnson JG, Taylor MH, Husain AA, Teichberg MC, Ferse SC.

PLoS One. 2016 Apr 21;11(4):e0154014. doi: 10.1371/journal.pone.0154014. eCollection 2016.

24.

Reply to: Letter to the Editor: Re Srinivasa et al., International Journal of Surgery 2014.

Srinivasa S, Taylor MH, Hill AG.

Int J Surg. 2016 May;29:187-8. doi: 10.1016/j.ijsu.2015.10.029. Epub 2015 Oct 30. No abstract available.

25.

Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.

Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukakis AG, Kiyota N, Taylor MH, Kim SB, Krzyzanowska MK, Dutcus CE, de las Heras B, Zhu J, Sherman SI.

N Engl J Med. 2015 Feb 12;372(7):621-30. doi: 10.1056/NEJMoa1406470.

26.

Goal-directed fluid therapy in major elective rectal surgery.

Srinivasa S, Taylor MH, Singh PP, Lemanu DP, MacCormick AD, Hill AG.

Int J Surg. 2014 Dec;12(12):1467-72. doi: 10.1016/j.ijsu.2014.11.010. Epub 2014 Nov 15.

27.

Blue lighting decreases the amount of food consumed in men, but not in women.

Cho S, Han A, Taylor MH, Huck AC, Mishler AM, Mattal KL, Barker CA, Seo HS.

Appetite. 2015 Feb;85:111-7. doi: 10.1016/j.appet.2014.11.020. Epub 2014 Nov 20.

PMID:
25447013
28.

Treatment Patterns and Health Outcomes Among Patients with Radioiodine-Refractory Differentiated Thyroid Cancer in the United States and Western Europe.

Gianoukakis AG, Flores NM, Pelletier CL, DiBonaventura M, Forsythe A, Wolfe G, Rege J, Taylor MH.

Value Health. 2014 Nov;17(7):A614. doi: 10.1016/j.jval.2014.08.2159. Epub 2014 Oct 26. No abstract available.

29.

Association between preoperative glucocorticoids and long-term survival and cancer recurrence after colectomy: follow-up analysis of a previous randomized controlled trial.

Singh PP, Lemanu DP, Taylor MH, Hill AG.

Br J Anaesth. 2014 Jul;113 Suppl 1:i68-73. doi: 10.1093/bja/aet577. Epub 2014 Feb 27.

30.

Systemic sclerosis and the heart.

Parks JL, Taylor MH, Parks LP, Silver RM.

Rheum Dis Clin North Am. 2014 Feb;40(1):87-102. doi: 10.1016/j.rdc.2013.10.007. Epub 2013 Nov 7. Review.

PMID:
24268011
31.

Systematic review and meta-analysis of oesophageal Doppler-guided fluid management in colorectal surgery.

Srinivasa S, Lemanu DP, Singh PP, Taylor MH, Hill AG.

Br J Surg. 2013 Dec;100(13):1701-8. doi: 10.1002/bjs.9294. Review.

PMID:
24227354
32.

The economics of fuel management: wildfire, invasive plants, and the dynamics of sagebrush rangelands in the western United States.

Taylor MH, Rollins K, Kobayashi M, Tausch RJ.

J Environ Manage. 2013 Sep 15;126:157-73. doi: 10.1016/j.jenvman.2013.03.044. Epub 2013 May 28.

PMID:
23722151
33.

The growing problem of illicit substance abuse in the elderly: a review.

Taylor MH, Grossberg GT.

Prim Care Companion CNS Disord. 2012;14(4). pii: PCC.11r01320. doi: 10.4088/PCC.11r01320. Epub 2012 Jul 12.

34.

Randomized clinical trial of goal-directed fluid therapy within an enhanced recovery protocol for elective colectomy.

Srinivasa S, Taylor MH, Singh PP, Yu TC, Soop M, Hill AG.

Br J Surg. 2013 Jan;100(1):66-74. doi: 10.1002/bjs.8940. Epub 2012 Nov 6.

35.

Perioperative fluid therapy in elective colectomy in an enhanced recovery programme.

Srinivasa S, Singh SP, Kahokehr AA, Taylor MH, Hill AG.

ANZ J Surg. 2012 Jul-Aug;82(7-8):535-40. doi: 10.1111/j.1445-2197.2012.06122.x. Epub 2012 Jul 3.

PMID:
22758595
36.

Oesophageal Doppler-guided fluid administration in colorectal surgery: critical appraisal of published clinical trials.

Srinivasa S, Taylor MH, Sammour T, Kahokehr AA, Hill AG.

Acta Anaesthesiol Scand. 2011 Jan;55(1):4-13. doi: 10.1111/j.1399-6576.2010.02308.x. Epub 2010 Sep 24. Review.

PMID:
21126237
37.

The ploidy conveyor of mature hepatocytes as a source of genetic variation.

Duncan AW, Taylor MH, Hickey RD, Hanlon Newell AE, Lenzi ML, Olson SB, Finegold MJ, Grompe M.

Nature. 2010 Oct 7;467(7316):707-10. doi: 10.1038/nature09414. Epub 2010 Sep 22.

38.

Role of transesophageal echocardiography among patients with atrial fibrillation undergoing electrophysiology testing.

Priester R, Bunting T, Usher B, Chiaramida S, Taylor MH, Gregg D, Sturdivant JL, Leman RB, Wharton JM, Gold MR.

Am J Cardiol. 2009 Nov 1;104(9):1256-8. doi: 10.1016/j.amjcard.2009.06.039. Epub 2009 Sep 16.

PMID:
19840572
39.

Forensic telepsychiatry in the United Kingdom.

Saleem Y, Taylor MH, Khalifa N.

Behav Sci Law. 2008;26(3):333-44. doi: 10.1002/bsl.810.

PMID:
18548516
40.

Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis.

Stelts S, Taylor MH, Nappi J, Van Bakel AB.

Ann Pharmacother. 2008 Jun;42(6):904-5. doi: 10.1345/aph.1K288. Epub 2008 Apr 22. No abstract available.

PMID:
18430794
41.

Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis.

Beall AD, Nietert PJ, Taylor MH, Mitchell HC, Shaftman SR, Silver RM, Smith EA, Bolster MB.

J Rheumatol. 2007 Jun;34(6):1277-82. Epub 2007 May 15.

PMID:
17516621
42.

Bradycardia with sevoflurane in siblings with Branchio-oto-renal syndrome.

Taylor MH, Wilton NC.

Paediatr Anaesth. 2007 Jan;17(1):80-3.

PMID:
17184439
43.
44.

Percutaneous occlusion of a pseudoaneurysm evolving after homograft aortic valve and root replacement with the Amplatzer muscular ventricular septal defect occluder.

Graham EM, Bandisode VM, Atz AM, Kline CH, Taylor MH, Ikonomidis JS.

J Thorac Cardiovasc Surg. 2006 Apr;131(4):914-6. No abstract available.

45.

Rhabdomyolysis with concurrent atorvastatin and diltiazem.

Lewin JJ 3rd, Nappi JM, Taylor MH.

Ann Pharmacother. 2002 Oct;36(10):1546-9.

PMID:
12243603
46.

Handheld computing in dentistry.

Taylor MH.

Dent Clin North Am. 2002 Jul;46(3):539-51, vii.

PMID:
12222096
47.

Weakfish sonic muscle: influence of size, temperature and season.

Connaughton MA, Fine ML, Taylor MH.

J Exp Biol. 2002 Aug;205(Pt 15):2183-8. Review.

48.

The acetyltransferase activity of CBP is required for wingless activation and H4 acetylation in Drosophila melanogaster.

Ludlam WH, Taylor MH, Tanner KG, Denu JM, Goodman RH, Smolik SM.

Mol Cell Biol. 2002 Jun;22(11):3832-41.

49.

Radiation-induced apoptosis in MOLT-4 cells requires de novo protein synthesis independent of de novo RNA synthesis.

Taylor MH, Buckwalter MR, Stephenson AC, Hart JL, Taylor BJ, O'Neill KL.

FEBS Lett. 2002 Mar 13;514(2-3):199-203.

50.

Ulnar artery involvement in systemic sclerosis (scleroderma).

Taylor MH, McFadden JA, Bolster MB, Silver RM.

J Rheumatol. 2002 Jan;29(1):102-6.

PMID:
11824945

Supplemental Content

Loading ...
Support Center